Month: June 2015

Stock Analysts

Apollo Education Falls Despite Q3 Earnings Beat, Lags Sales

June 30, 2015 0

Share price of Apollo Education Group, Inc. APOL declined almost 7% in afterhours trading as the post-secondary education provider reported lower-than-expected top line numbers in the third quarter of fiscal 2015 and reduced its fiscal 2015 guidance for the third time this year. Adjusted earnings of 53 cents per share in the third quarter of fiscal 2015 surpassed the Zacks Consensus Estimate of 47 cents per share by 12.8%. […]

Stock Analysts

ViaSat Advances Government Security Portfolio Offering

June 30, 2015 0

ViaSat Inc. VSAT disclosed advancement of its cyber security services and products portfolio for its federal clients. The company has decided to showcase its complete government product and cybersecurity service portfolio at the NSA-sponsored Information Assurance Symposium in Washington D.C […]

Mergers & Acquisitions

Cheng Cohen Attorneys Participate in International Roundtable at M&A Conference

June 30, 2015 0

Cheng Cohen Attorneys Participate in International Roundtable at M&A Conference PR Newswire CHICAGO, June 30, 2015 CHICAGO , June 30, 2015 /PRNewswire/ — Amy Cheng and Michael R. Daigle , partners at Cheng Cohen , the franchise industry’s premier full service boutique law firm, will participate in a roundtable on international mergers and acquisitions at the 2015 Summer Conference hosted by The Alliance of Merger & Acquisition Advisors (AM&AA). Approximately 500 private equity investors and other dealmakers are anticipated to attend the annual event in Chicago , July 7 through 9 . […]

Technicals

Do Investors Think Santander Consumer (SC) Stock is a Buy? – Tale of the Tape

June 30, 2015 0

If you are looking for a stock in the consumer sector, Santander Consumer USA Holdings Inc ( SC ) could be one to watch closely. Right now the company has a Zacks Rank #1 (Strong Buy) and it has been seeing rising earnings estimate revisions as of late. In fact, the full year consensus estimate has risen from $2.67/share to $2.70/share in the past 30 days, while two estimates have gone higher for the time frame and one have gone lower […]

Technicals

Are Investors Becoming Bullish on Synergetics (SURG) Stock Now? – Tale of the Tape

June 30, 2015 0

If you are looking for a stock in the consumer sector, Synergetics USA Inc ( SURG ) could be one to watch closely. Right now the company has a Zacks Rank #2 (Buy) and it has been seeing rising earnings estimate revisions as of late. In fact, the full year consensus estimate has risen from 12 cents per share to 16 cents share in the past 30 days, while one estimate have gone higher for the time frame and zero have gone lower […]

Technicals

Is the Crowd Right About Woodward (WWD) Stock? – Tale of the Tape

June 30, 2015 0

If you are looking for a stock in the consumer sector, Woodward Inc ( WWD ) could be one to watch closely. Right now the company has a Zacks Rank #2 (Buy) and it has been seeing rising earnings estimate revisions as of late. In fact, the full year consensus estimate has risen from $2.77/share to $2.81/share in the past 30 days, while two estimates have gone higher for the time frame and zero have gone lower […]

Mergers & Acquisitions

All Signs Lead to Olympic

June 30, 2015 0

All Signs Lead to Olympic Chicago’s Olympic Signs Acquires Some White Way Sign’s Assets at Recent Court Auction PR Newswire CHICAGO, June 30, 2015 CHICAGO , June 30, 2015 /PRNewswire/ — Former White Way customers, the writing’s on the wall: Olympic Signs ( www.olysigns.com ) is poised to meet Chicago’s signage needs. In a historic acquisition, Olympic Signs has assumed ownership of the following White Way assets, including customer list, maintenance files, and project record files. “What this means for White Way customers is a seamless transition,” says Rob Whitehead , Olympic Sign’s co-owner […]

Stock Analysts

Juno-Celgene in Immunotherapy Deal, Initial Deal Value $1B

June 30, 2015 0

Juno Therapeutics, Inc. JUNO and Celgene Corporation CELG announced an agreement covering the global development and commercialization of immunotherapies. The collaboration will see the companies leveraging T cell therapeutic strategies to develop treatments for patients with cancer and autoimmune diseases […]

Stock Analysts

Roche’s Multiple Sclerosis Studies Meet Primary Endpoint

June 30, 2015 0

Roche Holding AG RHHBY announced that two randomized, double-blind, double-dummy, multi-centre phase III studies (OPERA I and OPERA II) evaluating the efficacy and safety of ocrelizumab (600 mg intravenous infusion) have met their primary and major secondary endpoints. Both studies compared ocrelizumab to Merck KGaA MKGAF /Pfizer’s PFE Rebif for the treatment of people suffering from relapsing multiple sclerosis. The primary endpoint in both studies measured ocrelizumab’s ability to reduce the annualized relapse rate over a period of two years compared to Rebif […]